Glioblastomatous recurrence of oligodendroglioma remote from the original site: a case report

被引:5
作者
Kocaeli, Hasan [1 ]
Yakut, Tahsin
Bekar, Ahmet
Taskapilioglu, Ozgur
Tolunay, Sahsene
机构
[1] Uludag Univ, Sch Med, Dept Neurosurg, TR-16059 Bursa, Turkey
[2] Uludag Univ, Sch Med, Dept Med Genet, TR-16059 Bursa, Turkey
[3] Uludag Univ, Sch Med, Dept Pathol, TR-16059 Bursa, Turkey
来源
SURGICAL NEUROLOGY | 2006年 / 66卷 / 06期
关键词
oligodendroglioma; recurrence; glioblastoma multiforme; genetic analysis;
D O I
10.1016/j.surneu.2006.02.049
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: As in all diffuse gliomas, recurrence is an inherent feature of oligodendrogliomas, either as the same or higher grade neoplasm at the primary site. The rate of remote recurrence after surgery for the primary tumor cannot be estimated from the scarce literature, but delayed treatment of the primary tumor and genetic alterations may be associated with this phenomenon. Case Description: A 40-year-old man presented with generalized seizures. A magnetic resonance imaging scan disclosed a right frontal mass lesion showing features of a low-grade glioma for which he refused any treatment. Seven months after diagnosis upon uncontrollable seizures, he underwent a stereotactic biopsy, which was followed by a right frontal craniotomy, both of which confirmed the lesion as a grade 2 oligodendroglioma. Six months after surgery, the patient presented with a left frontal lobe GBM without evidence of recurrence at the primary site. The genetic analysis of the primary and recurrent tumors showed trisomy 7, monosomy 10, but not 1p or 19q deletions, which have been proposed as markers for favorable prognosis. Conclusion: Recurrence of a frontal lobe oligodendroglioma remote from the primary site as a GBM is a rare occurrence. Single-cell invasion across the corpus callosum with subsequent or simultaneous malignant degeneration into a secondary GBM is the likely mechanism. As the genetic analysis suggests, conversion of oligodendroglioma to GBM may be associated with gain of chromosome 7, loss of chromosome 10, and other genetic markers that may represent late events in the oncogenesis of oligodendroglial tumors. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:627 / 631
页数:5
相关论文
共 19 条
  • [1] AMALFITANO G, 1999, BRIT J CANCER, V81, P1371
  • [2] COULDWELL WT, 2001, BRAIN TUMORS ENCY AP, P525
  • [3] Oligodendrogliomas .1. Patterns of growth, histological diagnosis, clinical and imaging correlations: A study of 153 cases
    DaumasDuport, C
    Varlet, P
    Tucker, ML
    Beuvon, F
    Cervera, P
    Chodkiewicz, JP
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1997, 34 (01) : 37 - 59
  • [4] Oligodendroglioma: An appraisal of recent data pertaining to diagnosis and treatment
    Fortin, D
    Cairncross, GJ
    Hammond, RR
    [J]. NEUROSURGERY, 1999, 45 (06) : 1279 - 1291
  • [5] FULTS D, 1992, CANCER RES, V52, P674
  • [6] Fults D, 1998, INT J ONCOL, V12, P905
  • [7] Glioma invasion in the central nervous system
    Giese, A
    Westphal, M
    [J]. NEUROSURGERY, 1996, 39 (02) : 235 - 250
  • [8] Goussia AC, 2000, ONCOL REP, V7, P401
  • [9] Using mice to decipher the molecular genetics of brain tumors
    Hesselager, G
    Holland, EC
    [J]. NEUROSURGERY, 2003, 53 (03) : 685 - 694
  • [10] Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression
    Hoang-Xuan, K
    He, J
    Huguet, S
    Mokhtari, K
    Marie, Y
    Kujas, M
    Leuraud, P
    Capelle, L
    Delattre, JY
    Poirier, J
    Broët, P
    Sanson, M
    [J]. NEUROLOGY, 2001, 57 (07) : 1278 - 1281